Delivery Order SPE2DB22D2206-SPE2DB25FFL43
Award Date
2/5/25
Potential Completion Date
2/6/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DB20D7059|SPE2DB25FPWL4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,495.04 fixed-price delivery order is for the supply of 4,566,696,580 units of the medication Glycopyrrolate 1 mg/5 ml vial. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide glycopyrrolate 4 mg/20 ml vials. The contract, valued at $1,366.76, is a firm fixed-price delivery order with a completion date of May 28, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The $4,591.37 firm fixed-price delivery order is for the supply of the medication glycopyrrolate, with a 2-milliliter vial as the unit of measure. The contract has a period of performance through July 22, 2024 and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply the U.S. Department of Defense (DoD) and other government agencies with a specific medication, glycopyrrolate 0.2 mg/ml vial 20ml. The contract, valued at $2,704.75, is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,157.14 firm fixed-price delivery order is for the supply of 4 mg/20 ml vials of the medication glycopyrrolate. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies supporting...
This is a $1,160.22 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides the DLA with 4,566,945,412 units of the pharmaceutical product glycopyrrolate 1 mg/5 ml vial, 5 ml. The contract has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,025.07 delivery order is for the supply of 4 mg/20 ml vials of the drug glycopyrrolate, a medication used to treat various conditions. The contract is a Firm Fixed Price Delivery Order with a completion date of September 11, 2024. Amerisourcebergen, through its Corporate Office division, will provide these pharmaceutical products to support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,976.03, is for the delivery of 4567090353 GLYCOPYRROLATE 0.2 MG/ML VIAL 2ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is January 30, 2025. The contract is not designated with a set-aside. AmerisourceBergen...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of GLYCOPYRROLATE INJECT, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order with a firm fixed price of $8,856.68 and a completion date of May 25, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $7,774.29, is a firm fixed price delivery order for the supply of GLYCOPYRROLATE INJECT, a pharmaceutical product, with a period of performance through July 7, 2023. Amerisourcebergen Drug Corp holds an Indefinite Delivery...